Holen Sie sich die Stockscreener-App
3.82
2.14%
0.08
Handel nachbörslich:
3.83
0.01
+0.26%
Schlusskurs vom Vortag:
$3.74
Offen:
$3.78
24-Stunden-Volumen:
1.96M
Relative Volume:
0.55
Marktkapitalisierung:
$447.94M
Einnahmen:
$4.21M
Nettoeinkommen (Verlust:
$-97.67M
KGV:
-4.1075
EPS:
-0.93
Netto-Cashflow:
$-70.76M
1W Leistung:
-8.39%
1M Leistung:
+44.15%
6M Leistung:
-9.69%
1J Leistung:
-0.91%
1-Tages-Spanne:
$3.70
$3.96
1-Wochen-Bereich:
$3.5343
$4.31
52-Wochen-Spanne:
$2.45
$6.72
Absci Corp Stock (ABSI) Company Profile
Firmenname
Absci Corp
Sektor
Branche
Telefon
(360) 949-1041
Adresse
18105 SE MILL PLAIN BLVD, VANCOUVER
Vergleichen Sie ABSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
3.82 | 447.94M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-22 | Eingeleitet | Needham | Buy |
| 2024-10-02 | Eingeleitet | Guggenheim | Buy |
| 2024-07-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Eingeleitet | Truist | Buy |
| 2022-03-02 | Fortgesetzt | Cowen | Market Perform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-11-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | BofA Securities | Neutral |
| 2021-08-16 | Eingeleitet | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-16 | Eingeleitet | Stifel | Hold |
Alle ansehen
Absci Corp Aktie (ABSI) Neueste Nachrichten
Generative AI vs. cancer: Absci partners with Memorial Sloan Kettering for new therapeutics - MSN
Ballentine Partners LLC Takes $27,000 Position in Absci Co. (NASDAQ:ABSI) - Defense World
Absci (NASDAQ:ABSI) Earns Buy Rating from Analysts at Needham & Company LLC - Defense World
Cathie Wood's ARK sells Accolade stock, buys more Absci - MSN
Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a ‘Buy’ Rating from Needham - Insider Monkey
Cathie Wood's ARK sells Accolade stock, buys more Absci By Investing.com - Investing.com Australia
Absci Stock Surges with “Buy” Ratings from HC Wainwright and Guggenheim: What Investors Should Know - HPBL
Absci Corporation Soars 44% on Strategic AI Drug Discovery Partnership with AMD – Market - HPBL
Absci Corporation and AMD Partner to Revolutionize AI-Driven Drug Discovery – Market - HPBL
Absci (NASDAQ:ABSI) Now Covered by Needham & Company LLC - MarketBeat
Needham Initiates Coverage of Absci (ABSI) with Buy Recommendation - MSN
TSX Industrials EW Index (TXIE) QuotePress Release - The Globe and Mail
KBW Premium Yield Equity REIT Index (KYX) QuotePress Release - The Globe and Mail
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
KBW Regional Banking Index (KRX) QuotePress Release - The Globe and Mail
Absci shares jump as analyst lauds 'practical' AI drug company - The Business Journals
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales - Benzinga
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside - Benzinga
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings - Benzinga
Needham initiates Absci shares with Buy rating on strategy By Investing.com - Investing.com Canada
Needham initiates Absci shares with Buy rating on strategy - MSN
Needham & Company LLC Begins Coverage on Absci (NASDAQ:ABSI) - MarketBeat
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies - Benzinga
Absci Corp (ABSI-Q) QuotePress Release - The Globe and Mail
Absci Corporation Partners with AMD to Revolutionize AI-Powered Drug Discovery – Market - HPBL
Absci partners with semiconductor company AMD for AI drug discovery - Mobihealth News
Absci and Owkin synergise TechBio platforms to advance AI drug discovery - European Pharmaceutical Manufacturer
AMD and Absci Collaborate to Revolutionize AI-Driven Drug Discovery – Market - HPBL
Absci Co. (NASDAQ:ABSI) Short Interest Update - Defense World
Absci stock reiterated at Buy at H.C. Wainwright on AI-drug discovery leadership - MSN
Absci Shares Surge 27% on $20M Investment from AMD – Market - HPBL
Absci Co. (NASDAQ:ABSI) Short Interest Up 10.5% in December - MarketBeat
Barclays PLC Buys 104,083 Shares of Absci Co. (NASDAQ:ABSI) - MarketBeat
Complete List of All AI Companies Under $2 Billion Market Cap - Insider Monkey
Absci Corporation (ABSI): AI in Biopharma Discovery - Insider Monkey
Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) - Benzinga
Absci stock reiterated at Buy at H.C. Wainwright on AI-drug discovery leadership By Investing.com - Investing.com South Africa
Absci Corporation Shares Surge on Strategic Partnership with AMD – Market - HPBL
Absci's (ABSI) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
I: Weekly TechBio News - substack.com
Thinking about buying stock in Hanryu Holdings, Absci Corp, Spero Therapeutics, BioXcel Therapeutics, or Cybin? - Marketscreener.com
Absci Looks Cheap And Positioned For Growth With AMD’s AI Backing (NASDAQ:ABSI) - Seeking Alpha
Absci rises after report on $20M investment by Advanced Micro Devices - MSN
Absci Raising $20 Million From AMD - Pulse 2.0
Catherine Wood's Strategic Acquisition of Absci Corp Shares - GuruFocus.com
ABSIAbsci Corporation Latest Stock News & Market Updates - StockTitan
Absci, Owkin announce partnership to bring together AI platforms - Yahoo Finance
Absci Corporation and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery - Marketscreener.com
Finanzdaten der Absci Corp-Aktie (ABSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.49%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):